TAK

Q: What is the price of Takeda Pharmaceutical (TAK) today?

The price of Takeda Pharmaceutical (TAK) today is $ 17.76, with return of 23.53% compared to the last year. The price of Takeda Pharmaceutical (TAK) started the year trading around $ 15.59 and today it is at $ 17.76. Follow the real-time price chart, the historical price of Takeda Pharmaceutical (TAK) and international markets.

Q: When does Takeda Pharmaceutical (TAK) pay dividends?

Takeda Pharmaceutical (TAK) did not distribute dividends in the last year.

Q: Is Takeda Pharmaceutical (TAK) worth it?

Currently, Takeda Pharmaceutical (TAK) is priced at $ 17.76, with a P/E of 78.64%, representing a deviation of 3,985% from its historical average P/E. In the last year, the stock showed a variation of 23.53 in its price and distributed $ 0.00 in dividends, resulting in a Dividend Yield of 3.53%. The total shareholder return was 23.53%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How can I buy Takeda Pharmaceutical (TAK) stock?

Investing in stocks of Takeda Pharmaceutical (TAK) can be done in two ways: by buying the stock abroad. The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much would 100 shares of Takeda Pharmaceutical (TAK) yield today?

The yield of Takeda Pharmaceutical (TAK) was 1.89% in the last month, 23.53% in the last year and 22.29% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of $ 0.66 in dividends, with a Dividend Yield of 3.53%.If you wanted to buy 100 stocks of Takeda Pharmaceutical (TAK) today, the total investment would be $ 1,776.00, based on the current price of $ 17.76.If past performance were to repeat, the return on your investment would be:In 1 year: $ 2,193.89In 5 years: $ 2,171.87In 10 years: $ 1,984.15It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Takeda Pharmaceutical Co. Ltd.

Price

$ 17.76

return (12m)

23.53%

p/e

78.64

p/b

1.21

DIVIDEND YIELD

3.53%

price TAK

TAK

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return on Investment TAK

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

1.89%

3 months

28.07%

1 year

23.53%

2 years

34.82%

5 years

22.29%

10 years

11.72%

Fundamentals TAK

review the fundamentals of Takeda Pharmaceutical shares

P/E

78.64

Sector: -2.17 Industry: 0.11

P/S (Price-to-Sales)

1.98

Sector: 2.04 Industry: 2.54

P/B

1.21

Sector: 2.33 Industry: 2.50

DIVIDEND YIELD (DY)

3.53%

Sector: - Industry: -

ROA

0.76%

Sector: -27.04% Industry: -25.36%

ROE

1.54%

Sector: -30.90% Industry: -31.46%

ROIC

3.71%

Sector: -420.29% Industry: -78.33%

NET MARGIN

2.52%

Sector: -28.97% Industry: -29.82%

GROSS MARGIN

65.32%

Sector: 44.33% Industry: 50.66%

OPERATING MARGIN

7.77%

Sector: -24.52% Industry: -25.91%

EV/EBITDA

6.55

Sector: -0.57 Industry: 1.07

EV/EBIT

15.55

Sector: -2.95 Industry: -1.26

PRICE-TO-ASSETS

0.60

Sector: 1.23 Industry: 1.34

BVPS

15.53

Sector: 3.48 Industry: 4.82

EPS

0.24

Sector: -0.89 Industry: -0.87

EQUITY-TO-ASSETS RATIO

0.50

Sector: 0.42 Industry: 0.45

LIABILITIES / ASSETS

0.50

Sector: 0.47 Industry: 0.51

CAGR REVENUE 5 YEARS

-0.91%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

-28.36%

Sector: - Industry: -

FAIR VALUE OF Takeda Pharmaceutical ASSETS ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffet's mentor.

Current price

$ 17.76

Fair Value

$ 0.00

Upside Return potential.

-48.44%

See Graham's ranking

Because it considers equity value in its calculation, the formula does not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals TAK

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/b	ROE	dy	market cap	net margin
LLY	45.62	39.48	86.53%	0.57%	$ 941.53 B	31.66%
ISRG	62.59	9.96	15.92%	0.00%	$ 178.75 B	28.38%
TMO	29.23	3.66	12.52%	0.33%	$ 195.94 B	15.05%
SNY	13.02	1.41	10.86%	4.55%	$ 118.78 B	18.68%
NVS	22.66	6.81	30.04%	2.34%	$ 316.95 B	24.67%
ABT	31.01	3.95	12.73%	2.06%	$ 202.33 B	14.72%
MDT	27.16	2.55	9.38%	2.90%	$ 125.30 B	13.00%
GSK	15.59	5.57	35.71%	2.82%	$ 118.88 B	17.48%
CVS	57.39	1.35	2.35%	3.33%	$ 101.47 B	0.44%
BSX	39.33	0.00	0.00%	0.00%	$ 113.97 B	14.44%
TMDX	53.82	13.90	25.84%	0.00%	$ 4.94 B	16.20%
HCA	17.80	-43.58	-244.82%	0.54%	$ 120.77 B	8.97%
IDXX	49.59	32.73	65.99%	0.00%	$ 52.54 B	24.62%
RMD	25.12	5.91	23.51%	0.88%	$ 37.33 B	27.53%
DHR	41.21	2.83	6.88%	0.61%	$ 148.92 B	14.71%
INMD	9.23	1.27	13.73%	0.00%	$ 866.25 M	25.32%
FMS	11.89	0.80	6.75%	3.35%	$ 13.42 B	5.02%
PHG	29.32	2.36	8.06%	2.77%	$ 30.42 B	5.07%
SYK	45.72	6.62	14.48%	0.88%	$ 148.40 B	12.92%

Stock vs Indice Comparison Tool

If you had invested (change) 2 years years ago, ago, you would now have

R$ 1.000,00 in PETR4 You would now have R$ 2.294,60

R$ 1.000,00 in LEVE3 You would now have R$ 5.240,60

*The value considers the reinvestment of dividends.

TAK Historical Dividends

current DY: 3.53%

5-year average DY: 4.90%

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividend	09/30/2025	12/11/2025	0,32210000
Dividend	03/31/2025	07/07/2025	0,33900000
Dividend	09/30/2024	12/12/2024	0,33300000
Dividend	03/28/2024	07/08/2024	0,29220000
Dividend	09/29/2023	12/11/2023	0,31910000
Dividend	03/31/2023	07/10/2023	0,26900000
Dividend	09/30/2022	12/12/2022	0,30120000
Dividend	03/31/2022	07/11/2022	0,33010000
Dividend	09/30/2021	12/13/2021	0,39690000
Dividend	03/31/2021	07/12/2021	0,40660000
Dividend	09/30/2020	12/11/2020	0,43050000
Dividend	03/31/2020	07/06/2020	0,41900000
Dividend	09/30/2019	12/12/2019	0,41110000
Dividend	03/29/2019	07/10/2019	0,41720000
Dividend	09/28/2018	12/13/2018	0,39550000
Dividend	03/29/2018	07/09/2018	0,40640000
Dividend	09/29/2017	12/11/2017	0,39950000
Dividend	03/31/2017	07/10/2017	0,39890000
Dividend	09/30/2016	12/12/2016	0,39240000
Dividend	03/31/2016	07/11/2016	0,43700000
Dividend	09/30/2015	12/11/2015	0,36530000
Dividend	03/31/2015	07/09/2015	0,36530000
Dividend	09/29/2014	12/11/2014	0,37830000
Dividend	03/28/2014	07/10/2014	0,44370000
Dividend	09/27/2013	12/12/2013	0,43700000
Dividend	03/28/2013	07/08/2013	0,45710000
Dividend	09/27/2012	12/13/2012	0,54600000
Dividend	03/29/2012	07/09/2012	0,56380000
Dividend	09/29/2011	12/12/2011	0,57860000
Dividend	03/30/2011	07/07/2011	0,55580000
Dividend	09/29/2010	12/13/2010	0,53320000
Dividend	09/29/2009	12/15/2009	0,51780000
Dividend	03/30/2009	07/14/2009	0,48180000
Dividend	09/29/2008	12/16/2008	0,46810000

ABOUT THE COMPANY Takeda Pharmaceutical

Takeda Pharmaceutical Co. Ltd.

Average user rating I10

4.0 (14 people)

United States

101 years

Founded: 1925

2010

Time since IPO - 16 years

47.495

Employees

The Company Takeda Pharmaceutical Co. Ltd. (United States), is listed on NYSE with a market value of $ 59.19 Billions, having an equity of $ 49.03 Billions.

With a total of 47.495 employees, the company is listed in the sector of Health and categorized in industry of Main Medications.

In the last 12 months the Company had a revenue of $ 29.90 Billions, which generated a profit in the amount of $ 752.76 Millions.

As for its main indicators, the Company has a P/E ratio of 78.64, a P/BV ratio of 1.21 and in the last 12 months the dividend yield of TAK was at 3.53%.

The Company is traded internationally through the ticker TAK.

Market cap

$ 59.19 Billions

Net worth

$ 49.03 Billions

US$ 49,027,290,000.00

Assets

$ 98.83 Billions

US$ 98,828,040,000.00

Total Shares Outstanding

3.16 Billions

3,157,000,000

Average Daily Trading Volume

$ 3.01 Millions

US$ 3,007,974.52

Sector

Health

Industry

Main Medications

TAK

businesses that generate revenue for Takeda Pharmaceutical

Regions where Takeda Pharmaceutical generates revenue

TAK revenue and profits

Financial Results TAK

DRAG THE FRAME TO SEE MORE DATA

TAK cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

LBPSW - 4D pharma

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-300.00%

P/B

0.00

CVS - CVS Health

$ 78.69 25,20% (12M)

P/E

57.39

3.33%

ROE

2.35%

P/B

1.35

CI - Cigna

$ 281.27 --8,56% (12M)

P/E

11.22

2.08%

ROE

0.00%

P/B

0.00

CNC - Centene

$ 43.27 --27,22% (12M)

P/E

-3.31

0.00%

ROE

-33.28%

P/B

1.10

HUM - Humana

$ 180.75 --30,72% (12M)

P/E

17.71

1.86%

ROE

6.95%

P/B

1.23

HCA - HCA Healthcare

$ 534.47 67,63% (12M)

P/E

17.80

0.54%

ROE

-244.82%

P/B

-43.58

LLY - Eli Lilly

$ 983.26 14,10% (12M)

P/E

45.62

0.57%

ROE

86.53%

P/B

39.48

NVS - Novartis

$ 161.01 50,56% (12M)

P/E

22.66

2.34%

ROE

30.04%

P/B

6.81